medigraphic.com
SPANISH

Archivos de Neurociencias

Instituto Nacional de Neurología y Neurocirugía
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2023, Number 3

<< Back Next >>

Arch Neurocien 2023; 28 (3)

Case report: 29-year-old male with hemichorea-hemiballismus as the initial manifestation of cerebral toxoplasmosis in the setting of untreated HIV

Violante-Villanueva A, López-Hernández JC, Salas-Alvarado L, García X
Full text How to cite this article

Language: English
References: 14
Page: 40-43
PDF size: 216.23 Kb.


Key words:

hemiballismus, hemichorea, toxoplasmosis, HIV, basal ganglia, central nervous system.

ABSTRACT

Background: Hemichorea and hemiballismus are rare movement disorders caused by central nervous system toxoplasmosis. Objective: To describe the case of a male patient with treatmentnaïve HIV who initiated with right hemichorea and hemiballismus. Case report: We present a 29-year-old male with a history of untreated HIV. He presented to the emergency room with rightsided hemichorea and hemiballismus. The neurological examination was unremarkable, except for the presence of abnormal movements characterized by non-rhythmic, large-amplitude, violent and occasionally choreiform movements in the right side of his body. Brain MRI revealed a ringenhancing lesion in the left basal nuclei, raising suspicion of CNS toxoplasmosis. Further serologic tests confirmed the diagnosis. Treatment was initiated with trimethoprim-sulfamethoxazole, pyrimethamine/clindamycin and antiretrovirals. Haloperidol, aripiprazole, and clonazepam were administered to alleviate abnormal movements. Subsequent MRI scans showed radiological improvement, and the patient was discharged. Conclusion: Hemichorea-hemiballismus is a neurological manifestation unfrequently related to CNS toxoplasmosis. Prompt initiation of antiretroviral therapy and antimicrobial treatment is crucial to improve patient outcomes.


REFERENCES

  1. Bowen LN, Smith B, Reich D, Quezado M, Nath A. HIV-associatedopportunistic CNS infections: pathophysiology, diagnosis andtreatment. Nat Rev Neurol. 2016;12(11):662-74. doi: 10.1038/nrneurol.2016.149

  2. Patel AR, Patel AR, Desai S. Acute hemiballismus as the presentingfeature of parietal lobe infarction. Cureus. 2019;11(5):e4675.doi: 10.7759/cureus.4675

  3. Dimal NPM, Santos NJC, Reyes NGD, Astejada MN, JamoraRDG. Hemichorea-hemiballismus as a presentation of cerebritisfrom intracranial toxoplasmosis and tuberculosis. Tremor OtherHyperkinet Mov. 2021;11:2. doi: 10.5334/tohm.576

  4. Mattos JP, de Rosso AL, Corrêa RB, Novis S. Hemicoreaasociada a toxoplasmosis cerebral y SIDA. Arq Neuropsiquiatr.1995;53(3A):534.

  5. Postuma RB, Lang AE. Hemiballism: revisiting a classicdisorder. Lancet Neurol. 2003;2:661-8. doi: 10.1016/s1474-4422(03)00554-4

  6. Navia BA, Petito CK, Gold JWM, Cho E ‐S, Jordan BD, PriceRW. Cerebral toxoplasmosis complicating the acquired immunedeficiency syndrome: Clinical and neuropathological findings in27 patients. Ann Neurol. 1986;19(3):224-38.

  7. Kim JS. Case report: vesicocutaneous fistula. Can Fam Physician.2001;47(10):788-9.

  8. Tse W, Cersosimo MG, Gracies JM, Morgello S, OlanowCW, Koller W. Movement disorders and AIDS: a review.Park Relat Disord. 2004;10(6):323-34. doi: 10.1016/j.parkreldis.2004.03.001

  9. Marcus C, Feizi P, Hogg J, Summerfield H, Castellani R, SriwastavaS, et al. Imaging in differentiating cerebral toxoplasmosisand primary CNS lymphoma with special focus on FDG PET/CT. Am J Roentgenol. 2021;216(1):157-64. doi: 10.2214/AJR.19.22629

  10. Safarpour H, Cevik M, Zarean M, Barac A, Hatam-NahavandiK, Rahimi MT, et al. Global status of Toxoplasma gondii infectionand associated risk factors in people living with HIV. Aids.2020;34(3):469-74. doi: 10.1097/QAD.0000000000002424

  11. Schlüter D, Barragan A. Advances and challenges in understandingcerebral toxoplasmosis. Front Immunol. 2019;10:242. doi:10.3389/fimmu.2019.00242

  12. Vidal JE. HIV-related cerebral toxoplasmosis revisited: currentconcepts and controversies of an old disease. J Int AssocProvid AIDS Care. 2019;18:2325958219867315. doi:10.1177/2325958219867315

  13. Hernandez AV, Thota P, Pellegrino D, Pasupuleti V, Benites-ZapataVA, Deshpande A, et al. A systematic review and meta-analysisof the relative efficacy and safety of treatment regimens forHIV-associated cerebral toxoplasmosis: is trimethoprimsulfamethoxazolea real option? HIV Med. 2017;18(2):115-24.doi: 10.1111/hiv.12402

  14. Hosoda T, Mikita K, Ito M, Nagasaki H, Sakamoto M. Cerebraltoxoplasmosis with multiple hemorrhage lesions in an HIVinfected patient: A case report and literature review. Parasitol Int.2021;81:102280. doi: 10.1016/j.parint.2020.102280




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Arch Neurocien. 2023;28